Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions. Resolution With Dietary Modification and Statin Therapy

Journal of the American College of Cardiology

Volumn 52, Issue 23, 2008, Pages 1847-1857

  Fujimoto, Shinichiro ^a   Hartung, Dagmar ^a   Ohshima, Satoru ^a   Edwards, D Scott ^b   Zhou, Jun ^a   Yalamanchili, Padmaja ^b   Azure, Michael ^b   Fujimoto, Ai ^a   Isobe, Satoshi ^a   Matsumoto, Yuji ^a   Boersma, Hendricus ^c   Wong, Nathan ^a   Yamazaki, Junichi ^d   Narula, Navneet ^a   Petrov, Artiom ^a   Narula, Jagat ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

atherosclerosis; HMG coenzyme reductase inhibitor; matrix metalloproteinase; molecular imaging

Indexed keywords

FLUINDOSTATIN; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TECHNETIUM 99M; TRACER;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CHOLESTEROL DIET; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISOTOPE LABELING; MACROPHAGE; MALE; MOLECULAR IMAGING; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RABBIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ZYMOGRAPHY;

ANIMALS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; COMBINED MODALITY THERAPY; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MODELS, CHEMICAL; RABBITS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 56749107189     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.048     Document Type: Article

References (42)

1. Davies M., and Thomas A. Plaque fissuring: the cause of acute myocardial infarction, sudden death and crescendo angina. Br Heart J 53 (1985) 363-373
2. Virmani R., Kolodgie F.D., Burke A.P., Farb A., and Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20 (2000) 1262-1275
3. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
4. Lendon C.L., Davies M.J., and Born G.V. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 87 (1991) 87-90
5. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 (1994) 2493-2503
6. Shah P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophage induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569
7. Sukhova G.K., Schonbeck U., Rabkin E., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99 (1999) 2503-2509
8. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
9. Pasterkamp G., Schoneveld A.H., Hijnen D.J., et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteinases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 (2000) 245-253
10. Brown D.L., Hibbs M.S., Kearney M., Loushin C., and Isner J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 91 (1995) 2125-2131
11. Aikawa M., Rabkin E., Sugiyama S., et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103 (2001) 276-283
12. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97 (1998) 2433-2444
13. Fukumoto Y., Libby P., Rabkin E., et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 103 (2001) 993-999
14. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
15. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
16. Deguchi J.O., Aikawa M., Tung C.H., et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114 (2006) 55-62
17. Fujimoto S., Edwards D.S., Zhou J., et al. Molecular Imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. Circulation 116 (2007) II 560
18. Hartung D., Schafers M., Fujimoto S., et al. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions. Eur J Nucl Med Mol Imaging 34 (2007) S1-S8
19. Schafers M., Riemann B., Kopka K., et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109 (2004) r107-r112
20. Kolodgie F.D., Petrov A., Virmani R., et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled Annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 (2003) 3134-3139
21. Su H., Spinale F.G., Dobrucki L.W., et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation 112 (2005) 3157-3167
22. Xue C., Voss M., Nelson D., et al. Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo. J Med Chem 44 (2001) 2636-2660
23. Van der Wal A.C., Becker A.E., van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
24. Moreno P.R., Falk E., Palacios I.F., Newell J.B., Fuster V., and Fallon J.T. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90 (1994) 775-778
25. Varnava A.M., Mills P.G., and Davies M.J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105 (2002) 939-943
26. Welgus H.G., Campbell E.J., Curry J.D., et al. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation and cellular differentiation. J Clin Invest 86 (1990) 1496-1502
27. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 92 (1995) 402-406
28. Galis Z.S., Asanuma K., Godin D., and Meng X. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?. Circulation 97 (1998) 2445-2453
29. Nikkari S.T., O'Brien K.D., Ferguson M., et al. Interstitial collagenase-1 (MMP-1) expression in human carotid atherosclerosis. Circulation 92 (1995) 1393-1398
30. Li Z., Li L., Zielke H.R., et al. Increased expression of 72-kd type IV collagenase in human aortic atherosclerotic lesions. Am J Pathol 148 (1996) 121-128
31. Loftus I.M., Naylor A.R., Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute disruption. Stroke 31 (2000) 40-47
32. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. The relation of arterial geometry with luminal narrowing and plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 32 (1998) 655-662
33. Prescott M.F., Sawyer W.K., Von Linden-Reed J., et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice over expressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 878 (1999) 179-190
34. Luan Z., Chase A.J., and Newby A.C. Statins inhibit secretion of metalloproteinase-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 23 (2003) 769-775
35. Bellosta S., Via D., Canavesi V.N., et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18 (1998) 1671-1678
36. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91 (2002) 852-859
37. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinase: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
38. Gough P.J., Gomez I.G., Wile P.T., and Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116 (2006) 59-69
39. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
40. Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients cardiovascular disease. Circulation 107 (2003) 1579-1585
41. Eldrup N., Gromholdt M.L., Sillesen H., and Nordestgaard B.G. Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114 (2006) 1847-1854
42. Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 93 (1996) 1354-1363